Our aim is to help increase the speed of medical research globally and support medical institutions with digital patient-engagement tools.

We've developed a platform that helps medical researchers locate potential patient cohorts for their studies across multiple health institutions at the same time while keeping patient privacy intact. Moreover, the platform can be used to onboard patients into those medical studies with granular consent possibilities, as well as monitor their engagement through feedback surveys, risk calculators and patient diaries.

Longenesis was founded in 2019 by Emil Syundyukov, Sergey Jakimov and sector experts such as Insilico Medicine. They identified the problem of slow clinical research time due to difficulties with locating enough patients and keeping them engaged during the study. Longenesis was built with the aim of solving that.

Currently, we're working with a number of national and regional hospitals and pharmaceutical companies across nine countries in Europe and the MENA region, and we've empowered over 400 000 patients.

It was a great opportunity to polish our message and see what we needed to improve. Access to a pool of regional investors has also been a huge plus. We are also looking forward to participating in the Cocoon Ventures program this year.

Before you get onto that pitching stage, the jury might have already established an initial impression of you through your initial application.

For example, be very clear on what pain point you are solving and how big the opportunity is. You need to demonstrate that you know this topic in-depth. Also, show the experience and know-how your team brings to the table.

2022 has been a productive year, indeed! :) In 2023, we will focus on further building our traction and establishing ourselves in the CEE region, as it is a region where a lot of medical research takes place. We see a lot of opportunities here.

The state of the economy has definitely had an impact on our plans. It has helped us double-down on our commercialization strategy, focus on building multi-year collaborations instead of one-off projects and pilots, and in a "voluntold fashion," has made us better at prioritizing not just what we do but also what we don't do.

In five years, Longenesis aspires to become a one-stop shop for clinical trial initiation and compliant patient engagement for the leading study sponsors in the industry. We want to be at the forefront of changing the way secondary health data is used globally – where patients are at the center of decision-making and our digital solution empowers millions.

Within five years, we aspire to build a hospital network of 200+ institutions across the EU and MENA and actively expand in the US.

Strapping up and starting up is generally not the easiest route in life, so what motivated you personally to join the startup world? What keeps you on it daily?

What motivated me to work in the startup world is the thrill of seeing the impact that you can make – both with an innovative solution and as an individual in the whole organization. Also, no day is ever the same. If you are open to learning, admitting your own mistakes and going that extra mile to get things done, the possibilities to grow and leave an impact are endless.

What has been the best advice you have received about building a company?

The team will ultimately be the one that defines whether your startup makes it or not!